Acute Erythroid Leukemia (AEL) Latest Advances
Find the Latest Research About Acute Erythroid Leukemia (AEL)
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6091 publications
Flow Cytometric Detection of Intracellular Proteins in K562 Human Erythroleukemia Cells Using Unconjugated Primary Antibodies.
Journal: Journal of visualized experiments : JoVE
Published: September 09, 2026
Clinical analysis of 3 cases of childhood primary pure erythroid leukemia and literature review
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: September 07, 2026
Linezolid Acts as a Selective Inhibitor of the JAK2 V617F Mutation.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026
Prdx2 suppresses the erythroid differentiation by modulating the ROS-JNK1 signaling axis.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: May 20, 2026
Clinical characteristics and prognostic analysis of acute erythroid leukemia
Journal: Zhonghua nei ke za zhi
Published: May 08, 2026
Dual inhibition of tubulin and DNMT by the novel letermovir derivative H62 blocks leukemia.
Journal: Biochemical pharmacology
Published: April 21, 2026
Erythroblastic sarcoma with biallelic TP53 mutations and novel NUP214:: ABL1-new finding in erythroblastic sarcoma/acute erythroid leukemia.
Journal: Journal of hematopathology
Published: April 13, 2026
Previously undescribed antileukemic coumarins from Zanthoxylum dimorphophyllum var. spinifolium: isolation, structure elucidation, and mechanism insights.
Journal: Phytochemistry
Published: March 25, 2026
Interferon Receptor Chain Deficiency in Murine Friend Erythroleukemia Cell Clone Resistant to Type I or Type I and II Interferons.
Journal: International journal of molecular sciences
Published: March 05, 2026
The novel δ,γ-biscarboline derivative T2 suppresses erythroleukemia through inhibition of AKR1B1 in the fructose metabolic reprogramming.
Journal: Chemico-biological interactions
Published: December 28, 2025
Gastrodin enhances the spleen immune function in erythroleukemia by regulating T-cell receptor signaling pathway.
Journal: Medical oncology (Northwood, London, England)
Published: October 31, 2025
Last Updated: 11/08/2026